IBM Retirement Fund’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-6,225
Closed -$1.14M 762
2021
Q2
$1.14M Sell
6,225
-996
-14% -$171K 0.09% 203
2021
Q1
$1.1M Sell
7,221
-667
-8% -$103K 0.08% 227
2020
Q4
$1.23M Buy
7,888
+974
+14% +$125K 0.09% 211
2020
Q3
$791K Buy
6,914
+1,942
+39% +$210K 0.07% 253
2020
Q2
$558K Sell
4,972
-117
-2% -$12.4K 0.07% 246
2020
Q1
$457K Buy
5,089
+1,940
+62% +$190K 0.08% 240
2019
Q4
$341K Sell
3,149
-163
-5% -$17.4K 0.06% 274
2019
Q3
$324K Sell
3,312
-41
-1% -$4.62K 0.06% 287
2019
Q2
$439K Buy
3,353
+64
+2% +$8.25K 0.08% 218
2019
Q1
$445K Buy
3,289
+75
+2% +$9.33K 0.09% 206
2018
Q4
$313K Sell
3,214
-289
-8% -$34.2K 0.07% 251
2018
Q3
$487K Sell
3,503
-601
-15% -$75.4K 0.11% 204
2018
Q2
$510K Sell
4,104
-636
-13% -$74.3K 0.11% 212
2018
Q1
$528K Sell
4,740
-704
-13% -$84.1K 0.1% 231
2017
Q4
$715K Buy
5,444
+119
+2% +$14.5K 0.12% 204
2017
Q3
$820K Hold
5,325
0.15% 179
2017
Q2
$724K Buy
5,325
+2,901
+120% +$338K 0.13% 192
2017
Q1
$392K Sell
2,424
-17,995
-88% -$2.32M 0.11% 194
2016
Q4
$2.62M Sell
20,419
-91
-0.4% -$11.1K 0.11% 178
2016
Q3
$2.51M Sell
20,510
-8,028
-28% -$1.03M 0.13% 174
2016
Q2
$3.43M Buy
28,538
+335
+1% +$47.5K 0.12% 178
2016
Q1
$4.03M Sell
28,203
-24,513
-47% -$3.6M 0.15% 148
2015
Q4
$10.1M Buy
52,716
+23
+0% +$4.02K 0.19% 111
2015
Q3
$8.39M Buy
52,693
+157
+0.3% +$28.6K 0.18% 125
2015
Q2
$9.5M Buy
52,536
+3,797
+8% +$655K 0.18% 123
2015
Q1
$8.45M Sell
48,739
-60
-0.1% -$10.9K 0.16% 139
2014
Q4
$9.03M Sell
48,799
-224
-0.5% -$41.5K 0.17% 126
2014
Q3
$8.13M Sell
49,023
-1,449
-3% -$238K 0.16% 136
2014
Q2
$7.84M Buy
50,472
+95
+0.2% +$15K 0.15% 146
2014
Q1
$7.65M Sell
50,377
-27,666
-35% -$4.4M 0.15% 143
2013
Q4
$10.4M Sell
78,043
-2,920
-4% -$350K 0.14% 160
2013
Q3
$9.4M Sell
80,963
-11,614
-13% -$1.27M 0.13% 172
2013
Q2
$8.54M Buy
+92,577
New +$8.92M 0.11% 201

Other funds holding ALXN